Product Details

Mitoxantrone Ebewe 2 mg/mL Solution for Infusion is a powerful antineoplastic (chemotherapy) and immunosuppressant medication. It contains the active ingredient Mitoxantrone, a synthetic anthracenedione derivative known for its effectiveness in cancer treatment and management of certain autoimmune conditions. This medication is presented as a distinctive blue solution in a 10 mL vial, with each vial providing a total of 20 mg of Mitoxantrone. It is designed for intravenous administration exclusively by qualified healthcare professionals.

Benefits of Use

Mitoxantrone Ebewe offers significant therapeutic benefits in several critical medical areas:

It is highly effective in treating various forms of cancer, including acute non-lymphocytic leukemia (ANLL), specific types of non-Hodgkin's lymphoma, and hormone-refractory prostate cancer.

Furthermore, it is utilized to reduce neurological disability and decrease the frequency of clinical relapses in patients diagnosed with secondary progressive multiple sclerosis (SPMS).

The drug works by interfering with the synthesis and repair of DNA within rapidly dividing cells, which is a mechanism crucial for inhibiting the growth and proliferation of cancer cells and modulating immune responses.

How to Use

1. Mitoxantrone Ebewe must be administered intravenously (into a vein) only by qualified healthcare professionals who have experience in chemotherapy administration.

2. The solution requires dilution before administration, strictly following medical guidelines and protocols.

3. The precise dosage and duration of treatment will be determined by the treating physician, based on the specific medical condition, the patient's body surface area, and their response to treatment, including regular blood test results.

4. The infusion duration typically ranges from 5 to 30 minutes, which can vary depending on the specific dose and the extent of dilution.

5. Throughout the course of treatment, continuous and regular monitoring of blood counts, cardiac function, and liver function is absolutely crucial to ensure patient safety and optimize therapeutic outcomes.

Caution & Warnings

• This medicine can cause severe side effects, most notably bone marrow suppression (potentially leading to serious infections and bleeding complications) and cardiotoxicity (damage to the heart muscle), which may be irreversible.
• Cases of secondary leukemias have been reported following treatment with Mitoxantrone.
• Mitoxantrone Ebewe is not recommended for use during pregnancy or breastfeeding due to the significant potential for harm to the fetus or infant. Patients of reproductive potential must use effective contraception during and for a specified period after treatment.
• Patients should be vigilantly monitored for any signs of infection, abnormal bleeding, or emerging heart problems throughout the entire treatment course and during the follow-up period.
• Accidental contact of the solution with skin, eyes, or mucous membranes should be strictly avoided. In the event of such contact, wash the affected area thoroughly with soap and water immediately.
• It is imperative to inform your doctor about all other medications you are currently taking, including any over-the-counter drugs, herbal supplements, and vitamins, as significant drug interactions may occur.
• Administration of Mitoxantrone Ebewe should only occur under the direct supervision of a physician who is highly experienced in the safe and effective use of cytotoxic chemotherapy agents.

Ingredients

• Active Ingredient: Mitoxantrone hydrochloride equivalent to 2 mg/mL Mitoxantrone.
• Other Ingredients: Sodium chloride, sodium acetate trihydrate, acetic acid glacial (for pH adjustment), water for injection.